Vimarsana
Biggest News Aggregation in the World

Page 10 - Poster Presentations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Presentations Today - Breaking & Trending Today

FLORIDA SOUTHERN COLLEGE DOCTOR OF NURSING PRACTICE STUDENTS PRESENT CAPSTONE PROJECTS - Vimarsana News

FLORIDA SOUTHERN COLLEGE DOCTOR OF NURSING PRACTICE STUDENTS PRESENT CAPSTONE PROJECTS

/PRNewswire/ -- Members of the second graduating class of the Florida Southern College Doctor of Nursing Practice program presented their capstone project...

Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings - Vimarsana News

Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Functional Fluidics Shares Advances in Red Blood Cell Biomarkers at Foundation for Sickle Cell Disease Research's 16th Annual Symposium - Vimarsana News

Functional Fluidics Shares Advances in Red Blood Cell Biomarkers at Foundation for Sickle Cell Disease Research's 16th Annual Symposium

/PRNewswire/ -- In medical news, Functional Fluidics today announces that abstracts related to their red blood cell biomarker used in sickle cell disease...

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults - Vimarsana News

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults - Vimarsana News

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable...